EKF Diagnostics Holdings plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by 1. Julian Baines 2. Gavin Jones 3. Stephen Young 4. Christopher Mills 5. Christian Rigg 6. Jennifer Winter, was filed 26 Mar 2025.
EKF Diagnostics Holdings plc: what insiders have been doing
EKF Diagnostics Holdings plc belongs to the Health Care sector. Filings by its managers are published through RNS (LSE). The past year has been quiet: not a single insider filing for EKF Diagnostics Holdings plc. The previous disclosure was published on 26 March 2025.
Looking back to 2017, when coverage begins, insiders filed 6 purchases and 5 sales.
Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -20.9%Entry £0.27 · Close at T+365 £0.21
- +7.5%Entry £0.33 · Close at T+365 £0.36
- +41.0%Entry £0.33 · Close at T+365 £0.46
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate EKF Diagnostics Holdings plc Strong Buy (bullish), based on 3 analysts. Average price target: £0.35.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 0London Stock Exchange, AIMXRNS:5588850Canonical exit: 23 Jun 2025 (T+90)
- ▲25,780 GBP27RNS100,000 shares@ £0.257846.3% of flowLondon Stock Exchange, AIMXRNS:5118622Canonical exit: 20 Jun 2024 (T+90)
- ▲30,000 GBP27RNS100,000 shares@ £0.3053.7% of flowLondon Stock Exchange, AIMXRNS:5029144Canonical exit: 8 Apr 2024 (T+90)
- 11,000 shares@ £0.3261.7% of flowLondon Stock Exchange - AIMXISIN GB0031509804FCA-NSM:4410853Canonical exit: 18 Sept 2022 (T+90)
- 250,000 shares@ £0.807698.3% of flowLondon Stock Exchange - AIMXISIN GB0031509804FCA-NSM:4171138
- 500,000 shares@ £0.730543.7% of flowLondon Stock Exchange - AIMISIN GB0031509804FCA-NSM:3961231
- 3,963,591 shares@ £0.00839.5% of flowLondon Stock ExchangeISIN GB0031509804FCA-NSM:3950623
- 400,000 shares@ £0.33100.0% of flowLondon Stock ExchangeISIN GB0031509804FCA-NSM:LSE20190528070012_14088125_20200326185141287_6208-0
- 150,000 shares@ £0.331100.0% of flowLondon Stock ExchangeISIN GB0031509804FCA-NSM:LSE20190528070012_14088125_20200326185141287_6208-1Canonical exit: 22 Aug 2019 (T+90)
- 1,250,000 shares@ £0.272572.4% of flowLondon Stock ExchangeISIN GB0031509804FCA-NSM:LSE20181109134849_13862063_20200330111438778_21336
- ▲Executives2M GBP13FCA-NSM
11 of 11 declarations
About EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc is a company focused on the development and manufacture of medical diagnostic devices. It specializes in solutions for laboratory medicine and point-of-care healthcare.
